GT
DERM

Glenmede Trust’s Dermira, Inc. DERM Stock Holding History

Glenmede Trust’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-119
Closed – – 3199
2019
Q3 		$0 Hold
119
– – ﹤0.01% 3188
2019
Q2 		$1 Hold
119
– – ﹤0.01% 3024
2019
Q1 		$1 Hold
119
– – ﹤0.01% 3005
2018
Q4 		$0 Buy
+119
New +$1.3K ﹤0.01% 3131
2016
Q3 		– Sell
-5,827
Closed -$170K – 2719
2016
Q2 		$170K Buy
+5,827
New +$161K ﹤0.01% 1221

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Glenmede Trust's DERM Position: Q4 2019 in Review

Glenmede Trust sold out of Dermira, Inc. (DERM) in Q4 2019, closing a stake of 119 shares.

Glenmede Trust first reported a position in DERM in Q2 2016 and held it in 5 quarters. The position peaked at $170K in Q2 2016. 133 funds tracked by Wall St. Rank hold DERM as of Q4 2019.

  • Glenmede Trust reported no remaining Dermira, Inc. position as of Q4 2019 after selling out during the quarter.
  • Glenmede Trust sold 119 Dermira, Inc. shares in Q4 2019.
  • Glenmede Trust first reported a position in Dermira, Inc. in Q2 2016 and held it in 5 quarters.
  • Glenmede Trust's Dermira, Inc. position peaked at $170K in Q2 2016.
  • 133 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2019.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.